1-2 of 2
Aleksandra K. Butrym, MD PhD
Close
Sort by
Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Elzbieta Iskierka-Jazdzewska, MD, Anna Stepien, MSc, Federico Canzian, PhD, Alessandro Martino, PhD, Daniele Campa, PhD, Angelika Stein, Malgorzata Krawczyk-Kulis, MD PhD, Malwina Rybicka, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Aleksandra K. Butrym, MD PhD, Grzegorz Mazur, MD PhD, Artur J. Jurczyszyn, MD PhD, Daria Zawirska, MD PhD, Norbert Grzasko, MD PhD, Waldemar Tomczak, MD PhD, Edyta Subocz, MD PhD, Marzena Watek, MD, Marcin Pasiarski, MD PhD, Marcin Rymko, MD PhD, Malgorzata Calbecka, MD PhD, Agnieszka Druzd-Sitek, PhD, Jan Walewski, MD PhD, Marcin Kruszewski, MD PhD, Malgorzata Razny, MD PhD, Jan M Zaucha, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3628.
https://doi.org/10.1182/blood.V124.21.3628.3628
Published: 2014
Journal Articles

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, Jakub Debski, MD, Aleksandra K. Butrym, MD, PhD, Wojciech Legiec, Marek Hus, MD, PhD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan M Zaucha, Marcin Rymko, MD, Tigran Torosian, MD, Grzegorz Charlinski, Ewa Lech-Maranda, Artur J. Jurczyszyn, MD, PhD, Halina Urbanska-Rys, Agnieszka Druzd-Sitek, PhD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2013) 122 (21): 3236.
https://doi.org/10.1182/blood.V122.21.3236.3236
Published: 2013